Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: J Surg Oncol. 2021 May 3;124(3):324–333. doi: 10.1002/jso.26515

Table 1.

Difference-in-differences analysis of health insurance for pancreatic cancer patients in the pre- and post-expansion time periods in non-expansion and January 2014 expansion states.

Non-Expansion States Expansion States Unadjusted Adjusted
2011–12 2015–16 AD RC (%) 2011–12 2015–16 AD RC (%) DID p value DID p value
All patients (n) 25,871 33,031 21,186 26,915
Insurance Types (%)
Private 30.16 27.95 −2.21 −7.32 31.32 28.53 −2.79 −8.91 −0.58 0.30 −1.12 0.03 *
Medicare 58.18 61.81 3.63 6.25 59.01 61.64 2.63 4.45 −1.01 0.10 −0.31 0.54
Medicaid 5.04 4.44 −0.60 −11.85 5.95 7.57 1.62 27.29 2.22 <0.001 * 2.00 <0.001 *
Other Governmental 1.91 2.13 0.22 11.41 0.96 1.22 0.27 28.00 0.05 0.75 0.06 0.72
Uninsured 4.72 3.67 −1.05 −22.22 2.76 1.04 −1.73 −62.47 −0.68 0.002 * −0.64 0.004 *

AD=absolute difference (%); DID=difference-in-differences; RC=relative change (% change between time periods).

*

indicates statistical significance.